Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 31.68% is 151% above its 1-year average of -62.21%, near the high end of its 1-year range (-163.78%–31.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 134.16% above its 12-month average of -92.72%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 31.68%.
RETURN ON EQUITY (ROE)
31.68%
RETURN ON EQUITY (ROE) AVG TTM
-92.72%
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+134.16%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 96 covered companies
CURRENT VS SECTOR MEDIAN
+176.89%
vs the sector median at left
Hinge Health, Inc.
Market Cap
$7.56B
Return on Equity (ROE)
31.68%
TTM Avg
-92.72%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.02B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$6.63B
Return on Equity (ROE)
33.11%
TTM Avg
27.03%
3Y Avg
27.48%
5Y Avg
31.41%
Market Cap
$6.47B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$9.12B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$5.61B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
Market Cap
$9.67B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$5.35B
Return on Equity (ROE)
-25.83%
TTM Avg
-24.61%
3Y Avg
-23.01%
5Y Avg
-16.21%
Market Cap
$5.22B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hinge Health, Inc. (HNGE) | $7.56B | 31.68% | -92.72% | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 26.84% | -21.41% | -36.14% | -25.75% |
| Chemed Corporation (CHE)vs › | $6.63B | 33.11% | 27.03% | 27.48% | 31.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -43.83% | 25.09% | 5.57% | 0.40% |
| Insulet Corp. (PODD)vs › | $9.12B | 26.39% | 25.41% | 19.99% | 14.02% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -161.00% | -110.38% | -86.51% | -75.97% |
| Henry Schein, Inc. (HSIC)vs › | $9.67B | 12.77% | 11.88% | 12.69% | 13.50% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.35B | -25.83% | -24.61% | -23.01% | -16.21% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 18.24% | 20.62% | 17.32% | 27.02% |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | -0.17% | 18.91% | 22.60% | 24.60% |
ROE
31.7%
ROA
13.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 31.68% |
| 2026-03-31 | -163.78% |
| 2025-12-31 | -112.03% |
| 2025-09-30 | -105.20% |
| 2025-06-30 | -114.25% |
| 2025-03-31 | 30.96% |
| 2024-12-31 | -2.86% |
